Valuation: Molecule Group plc

Market Cap 55.64M 74.43M 66.46M 61.4M 104M 7.07B 106M 739M 293M 3.7B 279M 273M 11.67B P/E 2026 *
-7.58x
P/E 2027 * -31.1x
Enterprise Value 51.34M 68.67M 61.33M 56.65M 96.05M 6.52B 97.64M 682M 270M 3.42B 258M 252M 10.77B EV / Sales 2026 *
1.52x
EV / Sales 2027 * 1.15x
Free-Float
92.37%
Yield 2026 *
-
Yield 2027 * -
1 week-0.97%
1 month+5.97%
3 months-21.54%
6 months-11.30%
Current year-16.73%
1 week 200
Extreme 200
210
1 month 192.05
Extreme 192.05
220
Current year 190.55
Extreme 190.55
284
1 year 190.55
Extreme 190.55
284
3 years 190.55
Extreme 190.55
284
5 years 190.55
Extreme 190.55
284
10 years 190.55
Extreme 190.55
284
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-0.97%-16.73% - 74.43M
-1.67%-1.42%-0.60%+81.91% 173B
-0.18%-3.31%+26.05%+80.41% 142B
-0.03%+1.37%+36.17%+250.13% 97.75B
-0.66%+10.66%-23.88%+27.21% 94.37B
-0.73%+2.70%-16.39%+89.44% 84.86B
-1.88%+5.95%-24.49%+65.38% 81.99B
-1.17%+2.87%-12.39%+58.21% 75.23B
-1.74%+1.85%-8.31%+36.24% 66.63B
-0.01%+1.27%+46.44%+161.21% 45.79B
Average -0.81%+2.40%+0.59%+94.46% 86.18B
Weighted average by Cap. -0.93%+2.38%+2.47%+92.54%

Financials

2026 *2027 *
Net sales 33.7M 45.08M 40.25M 37.19M 63.05M 4.28B 64.09M 447M 177M 2.24B 169M 166M 7.07B 43.35M 57.99M 51.78M 47.84M 81.1M 5.5B 82.44M 576M 228M 2.88B 218M 213M 9.09B
Net income -5.9M -7.89M -7.05M -6.51M -11.04M -749M -11.22M -78.35M -31.02M -393M -29.62M -28.99M -1.24B -1.8M -2.41M -2.15M -1.99M -3.37M -229M -3.42M -23.9M -9.46M -120M -9.04M -8.84M -378M
Net Debt -4.3M -5.75M -5.14M -4.74M -8.04M -546M -8.18M -57.1M -22.61M -286M -21.59M -21.13M -902M -5.65M -7.56M -6.75M -6.23M -10.57M -717M -10.75M -75.03M -29.7M -376M -28.36M -27.76M -1.19B
Projected Income Statement - Annual - Molecule Group plc
Logo Molecule Group plc
Molecule Group plc, formerly Vulcan Two Group plc, is a United Kingdom-based company. The Company is focused on building a regulated ePharmacy platform through its buy-and-build. The Company has a diversified platform spanning business-to-business (B2B) prescription fulfillment and (B2C) digital pharmacy services. Its B2B platform is Molecule CloudRx, which is a regulated digital end-to-end prescription platform and B2B2C dispensing pharmacy, powered by a proprietary technology stack. Its B2C platforms are Molecule Clinic, Molecule through its own consumer-facing website. The Molecule Veterinary is a regulated Pharmacy, and Molecule Veterinary. The Molecule Clinic is a regulated B2C online clinic that prescribes and distributes weight loss and other lifestyle medications through a consumer-facing online consulting platform. Molecule Pharmacy is an over the counter (OTC) pharmacy offered and distributed digital pharmacy, dispensing and distributing private veterinary medications.
Employees
-
Date Price Change Volume
23/10/26 GBX 204.00 0.00% 2,506
22/10/26 GBX 204.00 +0.99% 24,958
21/10/26 GBX 202.00 -3.81% 6,792
20/10/26 GBX 210.00 +1.94% 13,123
19/10/26 GBX 206.00 0.00% 11,547
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
2.040GBP
Average target price
3.080GBP
Spread / Average Target
+50.98%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Molecule Group plc